小结
定义
病史和体格检查
关键诊断因素
- presence of risk factors
- jaundice
- non-specific upper abdominal pain or discomfort
- weight loss and anorexia
- back pain
其他诊断因素
- age 65-74 years
- steatorrhoea
- thirst, polyuria, nocturia, and weight loss
- nausea, vomiting, and early satiety
- unexplained acute pancreatitis
- hepatomegaly
- epigastric abdominal mass
- positive Courvoisier's sign
- petechiae, purpura, bruising
- Trousseau's sign (migratory thrombophlebitis)
危险因素
- smoking
- family history of pancreatic cancer
- other hereditary cancer syndromes
- chronic sporadic pancreatitis
- diabetes mellitus
- obesity
- dietary factors
诊断性检查
首要检查
- pancreatic protocol CT
- abdominal ultrasound
- LFTs
需考虑的检查
- prothrombin time (PT)
- FBC
- cancer antigen (CA)19-9 biomarker
- positron emission tomography
- endoscopic retrograde cholangiopancreatography (ERCP)
- MRI
- magnetic resonance cholangiopancreatography
- endoscopic ultrasound
- staging laparoscopy (with laparoscopic ultrasound)
- biopsy
新兴检查
- genomic testing
治疗流程
resectable (stages 1 and 2)
locally advanced unresectable (stage 3)
metastatic (stage 4)
撰稿人
作者
Hemant M. Kocher, MBBS, MS, MD, FRCS
Professor of Liver and Pancreas Surgery
Barts Cancer Institute
Barts and The London School of Medicine and Dentistry
London
UK
利益声明
HMK is an author of a number of references cited in this topic. HMK has received research grants from Bristol-Myers-Squibb (formerly Celgene) for investigator-initiated clinical trials. HMK has unrestricted educational grants from Meril, Mylan, Medtronics, and Ethicon.
鸣谢
Dr Hemant M. Kocher wishes to gratefully acknowledge Dr Fieke E.M. Froeling, a previous contributor to this topic.
利益声明
FEMF is an author of a reference cited in this topic.
同行评议者
Ross Carter, FRCS
Consultant Pancreatic Surgeon
West of Scotland Pancreatic Unit
Glasgow Royal Infirmary
Glasgow
UK
利益声明
Not disclosed.
Nikhil I. Khushalani, MD
Assistant Professor of Oncology
Roswell Park Cancer Institute
Buffalo
NY
利益声明
NIK has received funding for the conduction of clinical trials and associated translational studies from Merck, Pfizer, and Astra-Zeneca. NIK has a grant from the National Comprehensive Cancer Network (from research support by Roche).
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
参考文献
关键文献
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma [internet publication].全文
Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 Nov;34(11):987-1002.全文 摘要
National Institute for Health and Care Excellence. Pancreatic cancer in adults: diagnosis and management. Feb 2018 [internet publication].全文
Sohal DPS, Kennedy EB, Cinar P, et al. Metastatic pancreatic cancer: ASCO guideline update. J Clin Oncol. 2020 Aug 5:JCO2001364.全文 摘要
参考文献
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
鉴别诊断
- Chronic pancreatitis
- Bile duct stones
- Ampullary carcinoma
更多 鉴别诊断指南
- NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma
- Pancreatic cancer in adults: diagnosis and management
更多 指南患者教育信息
Pancreatic cancer
Pancreatic cancer: questions to ask your doctor
更多 患者教育信息登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明